Nialamide
|
WikiDoc Resources for Nialamide |
|
Articles |
|---|
|
Most recent articles on Nialamide |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Nialamide at Clinical Trials.gov Clinical Trials on Nialamide at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Nialamide
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Nialamide Discussion groups on Nialamide Directions to Hospitals Treating Nialamide Risk calculators and risk factors for Nialamide
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Nialamide |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Nialamide (Niamid, Niamide, Nuredal, Surgex) is a non-selective, irreversible monoamine oxidase inhibitor (MAOI) of the hydrazine class that was used as an antidepressant. It was withdrawn by Pfizer several decades ago due to the risk of hepatotoxicity.
